UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 188

Sortiert nach

Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors

Clinical chemistry and laboratory medicine, 2021-06, Vol.59 (7), p.1181

2021

Volltextzugriff (PDF)

EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance

Pharmacogenomics, 2018-06, Vol.19 (8), p.727-740

2018

Volltextzugriff (PDF)

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm

Oncology Reviews, 2020-07, Vol.14 (2), p.490-490

2020

Volltextzugriff (PDF)

Clinical pharmacology of intravitreal anti-VEGF drugs

Eye (London), 2018-06, Vol.32 (6), p.1010-1020

2018

Volltextzugriff (PDF)

Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel

The pharmacogenomics journal, 2021-04, Vol.21 (2), p.233-242

2021

Volltextzugriff (PDF)

Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers

Cancer, 2024-03, Vol.130 (6), p.848-850

2024

Volltextzugriff (PDF)

Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview

Anti-cancer agents in medicinal chemistry, 2022-02, Vol.22 (4), p.760

2022

Volltextzugriff (PDF)

EGFR signaling pathway as therapeutic target in human cancers

Seminars in cancer biology, 2022-10, Vol.85, p.253-275

2022

Volltextzugriff (PDF)

Circulating biomarkers of response to immunotherapy in cancer treatment

Pharmacogenomics, 2019-12, Vol.20 (18), p.1247-1249

2019

Volltextzugriff (PDF)

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

European urology, 2017-04, Vol.71 (4), p.680-687

2017

Volltextzugriff (PDF)

4th ESPT Conference: pharmacogenomics and personalized medicine – research progress and clinical implementation

Pharmacogenomics, 2019-10, Vol.20 (15), p.1063-1069

2019

Volltextzugriff (PDF)

Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low‐grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis?

Histopathology, 2024-08, Vol.85 (2), p.244-253

2024

Volltextzugriff (PDF)

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

Frontiers in oncology, 2019-06, Vol.9, p.547-547

2019

Volltextzugriff (PDF)

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

Breast cancer research and treatment, 2019-11, Vol.178 (1), p.57-62

2019

Volltextzugriff (PDF)

Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer

Critical reviews in oncology/hematology, 2021-07, Vol.163, p.103366-103366, Article 103366

2021

Volltextzugriff (PDF)

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

European urology, 2021-06, Vol.79 (6), p.762-771

2021

Volltextzugriff (PDF)

Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non‐Small Cell Lung Cancer: The Role of Cancer Stem Cells

Stem cells (Dayton, Ohio), 2018-05, Vol.36 (5), p.633-640

2018

Volltextzugriff (PDF)

Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence

Journal of medical virology, 2022-02, Vol.94 (2), p.491-498

2022

Volltextzugriff (PDF)

Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

International journal of molecular sciences, 2019-08, Vol.20 (16), p.3951

2019

Volltextzugriff (PDF)

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide

Cancer treatment reviews, 2017-04, Vol.55, p.71-82

2017

Volltextzugriff (PDF)

Androgen receptor (AR) splice variant 7 and full‐length AR expression is associated with clinical outcome: a translational study in patients with castrate‐resistant prostate cancer

BJU international, 2019-10, Vol.124 (4), p.693-700

2019

Volltextzugriff (PDF)

A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC

Cancer Immunology, Immunotherapy, 2021-06, Vol.70 (6), p.1667-1678

2021

Volltextzugriff (PDF)

Pathophysiology and pharmacological targets of VEGF in diabetic macular edema

Pharmacological research, 2016-01, Vol.103, p.149-157

2016

Volltextzugriff (PDF)

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer

Scientific reports, 2017-08, Vol.7 (1), p.7931-8, Article 7931

2017

Volltextzugriff (PDF)

Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro

Cancer chemotherapy and pharmacology, 2018-04, Vol.81 (4), p.745-754

2018

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(18)
Pharmacogenomics
(15)
Critical Reviews In Oncology/hematology
(14)
Cancers
(9)
Cancer Treatment Reviews
(7)
Frontiers In Oncology
(5)
The Epma Journal
(5)
The epma Journal
(5)
Blood
(4)
Clinical Lung Cancer
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors

EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm

Clinical pharmacology of intravitreal anti-VEGF drugs

Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel

Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers

Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview

EGFR signaling pathway as therapeutic target in human cancers

Circulating biomarkers of response to immunotherapy in cancer treatment

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

4th ESPT Conference: pharmacogenomics and personalized medicine – research progress and clinical implementation

Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low‐grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis?

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non‐Small Cell Lung Cancer: The Role of Cancer Stem Cells

Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence

Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide

Androgen receptor (AR) splice variant 7 and full‐length AR expression is associated with clinical outcome: a translational study in patients with castrate‐resistant prostate cancer

A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC

Pathophysiology and pharmacological targets of VEGF in diabetic macular edema

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer

Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro

Suchergebnisse filtern